Bard D R, Knight C G, Page Thomas D P
Clin Exp Rheumatol. 1983 Apr-Jun;1(2):113-7.
The application of radiosynovectomy to patients with rheumatoid arthritis has been severely restricted by the difficulty of preventing leakage of the radioisotope from the joint cavity. We have synthesised a lipophilic chelator, 3-cholesteryl 6-[N'-iminobis(ethylenenitrilo)-tetraacetic acid]hexyl ether (Chol-DTTA) which can complex with a variety of beta-emitting radionuclides and is incorporated into the lipid phase of liposomes. The retention in the synovial cavities of rabbit knees of liposomes containing Chol-DTTA, complexed with the gamma-emitting tracer 51Cr, has been measured over a period of 21 days and compared with colloidal and water-soluble preparations. The distribution of the radionuclide between the tissues of the joint was also examined. Results show retention of 51Cr delivered in chelator liposomes to be greater than 99% after 24 h. At this time, over 93% of the radioactivity had become associated with the synovium. We conclude that chelator liposomes offer considerable promise as vehicles for radioisotopes in radiosynovectomy.
放射性滑膜切除术在类风湿性关节炎患者中的应用因难以防止放射性同位素从关节腔泄漏而受到严重限制。我们合成了一种亲脂性螯合剂,3-胆固醇基6-[N'-亚氨基双(乙二腈)-四乙酸]己基醚(Chol-DTTA),它可以与多种发射β射线的放射性核素络合,并被纳入脂质体的脂质相中。含有与发射γ射线的示踪剂51Cr络合的Chol-DTTA的脂质体在兔膝关节滑膜腔中的滞留情况已在21天内进行了测量,并与胶体和水溶性制剂进行了比较。还检查了放射性核素在关节组织之间的分布。结果显示,螯合剂脂质体递送的51Cr在24小时后保留率大于99%。此时,超过93%的放射性与滑膜相关。我们得出结论,螯合剂脂质体作为放射性滑膜切除术中放射性同位素的载体具有很大的前景。